| |
|
|
|
Celldex Therapeutics Inc.  
|
|
26.21 1.01 (0.04%) |
03-05 16:00 |
|
Open: |
25.25 |
Pre close: |
25.2 |
Target:
|
35.24
|
|
High: |
26.3 |
Low: |
22.62 |
Resistance:
|
30.17
35.24
|
|
Volume: |
529,090 |
Market Cap: |
1037M |
Support:
|
24.32
 20.70
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
27.21
 |
MACD |
MACD(12,26):
|
1.55 |
|
MA(20): |
26.06 |
Signal(12,26,9): |
1.89 |
|
MA(100): |
19.95 |
Stochastic Oscillator |
%K(14,3):
|
45.33 |
|
MA(250): |
12.67 |
%D(3): |
62.04 |
|
Average Volume(K) |
3-Month: |
65749
|
52-Week |
High:
|
30.17 |
|
10-Days: |
58604 |
Low: |
1.50 |
|
RSI |
RSI(14):
|
55.10 |
Change(%): |
1096.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.030 |
Return on Equity (ttm) |
-29.2 |
Shares Out. (M) |
39.57 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-16.8 |
Shares Float (M) |
28.85 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.16 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
22.3 |
% Held by Institutions |
82.07 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
-0.988 |
Shares Short (K) |
3440 |
|
Book Value (p.s.) |
5.810 |
EBITDA (p.s.) |
-1.204 |
P/E |
-12.91 |
|
Sales Per Share |
0.114 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.51 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-46.19 |
P/S |
229.45 |
|
Operating Margin |
-1150.00 |
Levered Free Cash Flow
(M) |
-26.08 |
P/CF |
-22.45 |
|
|
|
|
|
|
